Polatuzumab Vedotin + Obinutuzumab + Venetoclax In Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (Fl): Primary Analysis Of A Phase 1b/2 Trial
dc.contributor.author | Bannerji, R. | |
dc.contributor.author | Yuen, S. | |
dc.contributor.author | Phillips, T. | |
dc.contributor.author | Arthur, C. | |
dc.contributor.author | Isufi, I. | |
dc.contributor.author | Marlton, P. | |
dc.contributor.author | Seymour, J. F. | |
dc.contributor.author | Corradini, P. | |
dc.contributor.author | Molinari, A. | |
dc.contributor.author | Gritti, G. | |
dc.contributor.author | Emmons, R. | |
dc.contributor.author | Hirata, J. | |
dc.contributor.author | Musick, L. | |
dc.contributor.author | Saha, S. | |
dc.contributor.author | Croft, B. | |
dc.contributor.author | Flowers, C. | |
dc.date.accessioned | 2021-07-01T20:11:03Z | |
dc.date.available | 2022-07-01 16:11:02 | en |
dc.date.available | 2021-07-01T20:11:03Z | |
dc.date.issued | 2021-06 | |
dc.identifier.citation | Bannerji, R.; Yuen, S.; Phillips, T.; Arthur, C.; Isufi, I.; Marlton, P.; Seymour, J. F.; Corradini, P.; Molinari, A.; Gritti, G.; Emmons, R.; Hirata, J.; Musick, L.; Saha, S.; Croft, B.; Flowers, C. (2021). "Polatuzumab Vedotin + Obinutuzumab + Venetoclax In Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (Fl): Primary Analysis Of A Phase 1b/2 Trial." Hematological Oncology 39: n/a-n/a. | |
dc.identifier.issn | 0278-0232 | |
dc.identifier.issn | 1099-1069 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/168282 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.title | Polatuzumab Vedotin + Obinutuzumab + Venetoclax In Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (Fl): Primary Analysis Of A Phase 1b/2 Trial | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Otolaryngology | |
dc.subject.hlbsecondlevel | Neurosciences | |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | |
dc.subject.hlbsecondlevel | Oncology and Hematology | |
dc.subject.hlbsecondlevel | Ophthalmology | |
dc.subject.hlbsecondlevel | Public Health | |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/168282/1/hon23_2880.pdf | |
dc.identifier.doi | 10.1002/hon.23_2880 | |
dc.identifier.source | Hematological Oncology | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.